How this model should be used
The presented model is used to predict the preinterventional risk of aneurysmal rebleeding within 24 and 72 hours after aneurysmal subarachnoid hemorrhage. The prediction score has been developed based on multinational cohort data from two prospective hospital registries and three retrospective observational studies in Europe (n = 2075, of whom 269 suffered preinterventional rebleeding; DOI: 10.1227/neu.0000000000002045). The score has been externally validated using data from two European hospital registries (n = 1467, of whom 143 suffered preinterventional rebleeding; DOI: 10.1227/neu.0000000000003275).
Context information
Because this validation study used observational data, it is difficult to rule out selection- and information bias. Although the DCA suggests clinical usefulness, the real scientific test of how the ARISE models affect decision-making in daily clinical patient care is an impact study. This prediction tool should be used exclusively by health care professionals as a complementary tool to estimate the preinterventional rebleeding risk. Using it, you should understand and agree that the authors are not responsible or liable for any claim, loss, or damage resulting from its use. While we try to keep the model as accurate as possible, we disclaim any warranty concerning its accuracy, timeliness, and completeness, and any other warranty, express or implied, including warranties of merchantability or fitness for a particular purpose.
Model performance
The ARISE base model showed promise at external validation. The ARISE base model has good discriminative ability for the prediction of a preinterventional rebleed in patients suffering from aSAH (c-statistic >0.70), although updating the baseline hazard for each center was needed to obtain adequate model calibration. After local validation and adjustment of the baseline hazard if required, the ARISE base model may well be used for risk prediction in patients with aSAH facilitating future endeavors to minimize the risk of preinterventional rebleeding.
Este algoritme se proporciona con fines educativos, formativos e informativos. No debe utilizarse para apoyar la toma de decisiones médicas ni para prestar servicios médicos o de diagnóstico. Lea nuestro Descargo de responsabilidad.
| {{ (typeof row === 'object') ? row.label : row }} |
{{ result.result }}
|
|
Evidencio B.V., Irenesingel 19, 7481 GJ Haaksbergen, Países bajos |
|
|
{{ model.lot }} |
| {{ model.electronicLabelWarning }} | |
|
|
{{ model.udi }} |
|
|
{{ model.representative }} |
|
|
Descargar el Manual de usuario |
|
|
Productos sanitarios Productos sanitarios para diagnóstico in vitro |
{{ error }}
Por favor, introduzca una contraseña
Una contraseña debe tener al menos 8 caracteres
Una contraseña no puede tener más de 64 caracteres
Elija una contraseña con al menos una letra mayúscula
Elija una contraseña con al menos un carácter especial (@$!%*#?&)
Por favor, acepte los Términos y Condiciones y el Aviso Legal
Proporcione su dirección de correo electrónico y le enviaremos un enlace para restablecer su contraseña
Dirección de correo electrónico
Por favor, introduzca un correo electrónico válido
Si se registró una cuenta con esta dirección de correo electrónico, recibirá un enlace de recuperación en su correo
Por favor, utiliza el enlace de restablecimiento de contraseña que aparece en él para establecer tu nueva contraseña
¿Aún no has recibido el correo? Por favor, comprueba tu carpeta de spam, o reenviar el correo electrónico